Clinical Trial Update: R-BL-M-04 Versus R-(DA)-EPOCH and Autologous Stem Cells Transplantation in Patients With High-Grade B-cell Lymphoma Double-hit (HGBL DH) and High-Grade B-cell Lymphoma Not Otherwise Specified (HGBL NOS) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing R-BL-M-04 to Rituximab plus DA-EPOCH with autologous stem cell transplantation in high-grade B-cell lymphoma subtypes (double-h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade B-cell Lymphoma Double-hit
• High-grade B-cell Lymphoma Not Otherwise Specified

Drugs mentioned

• Autologous stem cell transplantation (autologous stem cell transplantation)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• Etoposide (Etoposide)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: Elena N.Parovichnikova | Conditions: Lymphoma, High-Grade | Phase 3 | Status: UNKNOWN